Filed: 11/4/2025ACC: 0001381843-25-000009
📋 What this filing means
ATLE FUND MANAGEMENT AB filed this quarterly 13F‑HR report disclosing 38 equity positions with a total reported market value of $26.97M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
38
Positions
$26.97M
Total AUM (reported)
4.59M
Total Shares
Allocation by class
COM$22.59M83.8%
COM NEW$1.30M4.8%
SPONSORED ADS$1.10M4.1%
SHS$805.4K3.0%
ORDINARY SHARES$584.6K2.2%
SPON ADS$369.7K1.4%
COMMON STOCK$224.3K0.8%
Portfolio Concentration
Top 3$6.81M25.3%
4–10$7.70M28.5%
11–25$9.27M34.4%
Rest$3.19M11.8%
Top 3 weight
25.3%
Top 10 weight
53.8%
Voting Authority Distribution
Total shares with voting rights: 26.97M
Sole
Full voting authority
26.97M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole38
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings38
Rows:
Eli Lilly & Co
SOLEShares37.24K
TypeSH
Market value$3.02M
11.19%
Sole
3.02M
Shared
0.00
None
0.00
AbbVie Inc
SOLEShares92.11K
TypeSH
Market value$2.26M
8.40%
Sole
2.26M
Shared
0.00
None
0.00
Neurocrine Biosciences Inc
SOLEShares102.63K
TypeSH
Market value$1.53M
5.67%
Sole
1.53M
Shared
0.00
None
0.00
Merck & Co. Inc
SOLEShares160.91K
TypeSH
Market value$1.43M
5.32%
Sole
1.43M
Shared
0.00
None
0.00
Thermo Fisher Scientific Corp
SOLEShares27.15K
TypeSH
Market value$1.40M
5.18%
Sole
1.40M
Shared
0.00
None
0.00
BeiGene Ltd
SOLEShares30.33K
TypeSH
Market value$1.10M
4.07%
Sole
1.10M
Shared
0.00
None
0.00
Bridgebio Pharma Inc
SOLEShares174.72K
TypeSH
Market value$963.4K
3.57%
Sole
963.44K
Shared
0.00
None
0.00
Cencora Inc
SOLEShares28.61K
TypeSH
Market value$949.2K
3.52%
Sole
949.20K
Shared
0.00
None
0.00
Intuitive Surgical Inc
SOLEShares19.71K
TypeSH
Market value$935.7K
3.47%
Sole
935.68K
Shared
0.00
None
0.00
Gilead Sciences Inc
SOLEShares78.17K
TypeSH
Market value$921.2K
3.42%
Sole
921.16K
Shared
0.00
None
0.00
Boston Scientific Corp
SOLEShares86.68K
TypeSH
Market value$898.4K
3.33%
Sole
898.42K
Shared
0.00
None
0.00
Stryker Corporation
SOLEShares22.77K
TypeSH
Market value$893.6K
3.31%
Sole
893.58K
Shared
0.00
None
0.00
Alkermes PLC
SOLEShares252.88K
TypeSH
Market value$805.4K
2.99%
Sole
805.39K
Shared
0.00
None
0.00
Krystal Biotech, Inc
SOLEShares42.19K
TypeSH
Market value$790.7K
2.93%
Sole
790.71K
Shared
0.00
None
0.00
Vertex Pharmaceuticals Inc
SOLEShares17.77K
TypeSH
Market value$738.7K
2.74%
Sole
738.67K
Shared
0.00
None
0.00
Mirum Pharmaceuticals Inc
SOLEShares93.61K
TypeSH
Market value$728.5K
2.70%
Sole
728.52K
Shared
0.00
None
0.00
NewAmsterdam Pharma Co NV
SOLEShares193.63K
TypeSH
Market value$584.6K
2.17%
Sole
584.61K
Shared
0.00
None
0.00
iRhythm Technologies Inc
SOLEShares29.99K
TypeSH
Market value$547.6K
2.03%
Sole
547.61K
Shared
0.00
None
0.00
Edwards Lifesciences Corp
SOLEShares65.66K
TypeSH
Market value$542.1K
2.01%
Sole
542.11K
Shared
0.00
None
0.00
Cardinal Health Inc
SOLEShares30.30K
TypeSH
Market value$504.9K
1.87%
Sole
504.85K
Shared
0.00
None
0.00
UFP Technologies Inc
SOLEShares22.99K
TypeSH
Market value$487.1K
1.81%
Sole
487.08K
Shared
0.00
None
0.00
Merus N.V.
SOLEShares48K
TypeSH
Market value$479.8K
1.78%
Sole
479.77K
Shared
0.00
None
0.00
Soleno Therapeutics Inc
SOLEShares60.16K
TypeSH
Market value$431.7K
1.60%
Sole
431.72K
Shared
0.00
None
0.00
REVOLUTION Medicines Inc
SOLEShares85.36K
TypeSH
Market value$423.2K
1.57%
Sole
423.18K
Shared
0.00
None
0.00
Amgen Inc
SOLEShares13.81K
TypeSH
Market value$413.6K
1.53%
Sole
413.62K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Eli Lilly & CoSOLE | COM | 37.24K | SH | $3.02M 11.19% | 3.02M | 0.00 | 0.00 |
AbbVie IncSOLE | COM | 92.11K | SH | $2.26M 8.40% | 2.26M | 0.00 | 0.00 |
Neurocrine Biosciences IncSOLE | COM | 102.63K | SH | $1.53M 5.67% | 1.53M | 0.00 | 0.00 |
Merck & Co. IncSOLE | COM | 160.91K | SH | $1.43M 5.32% | 1.43M | 0.00 | 0.00 |
Thermo Fisher Scientific CorpSOLE | COM | 27.15K | SH | $1.40M 5.18% | 1.40M | 0.00 | 0.00 |
BeiGene LtdSOLE | SPONSORED ADS | 30.33K | SH | $1.10M 4.07% | 1.10M | 0.00 | 0.00 |
Bridgebio Pharma IncSOLE | COM | 174.72K | SH | $963.4K 3.57% | 963.44K | 0.00 | 0.00 |
Cencora IncSOLE | COM | 28.61K | SH | $949.2K 3.52% | 949.20K | 0.00 | 0.00 |
Intuitive Surgical IncSOLE | COM NEW | 19.71K | SH | $935.7K 3.47% | 935.68K | 0.00 | 0.00 |
Gilead Sciences IncSOLE | COM | 78.17K | SH | $921.2K 3.42% | 921.16K | 0.00 | 0.00 |
Boston Scientific CorpSOLE | COM | 86.68K | SH | $898.4K 3.33% | 898.42K | 0.00 | 0.00 |
Stryker CorporationSOLE | COM | 22.77K | SH | $893.6K 3.31% | 893.58K | 0.00 | 0.00 |
Alkermes PLCSOLE | SHS | 252.88K | SH | $805.4K 2.99% | 805.39K | 0.00 | 0.00 |
Krystal Biotech, IncSOLE | COM | 42.19K | SH | $790.7K 2.93% | 790.71K | 0.00 | 0.00 |
Vertex Pharmaceuticals IncSOLE | COM | 17.77K | SH | $738.7K 2.74% | 738.67K | 0.00 | 0.00 |
Mirum Pharmaceuticals IncSOLE | COM | 93.61K | SH | $728.5K 2.70% | 728.52K | 0.00 | 0.00 |
NewAmsterdam Pharma Co NVSOLE | ORDINARY SHARES | 193.63K | SH | $584.6K 2.17% | 584.61K | 0.00 | 0.00 |
iRhythm Technologies IncSOLE | COM | 29.99K | SH | $547.6K 2.03% | 547.61K | 0.00 | 0.00 |
Edwards Lifesciences CorpSOLE | COM | 65.66K | SH | $542.1K 2.01% | 542.11K | 0.00 | 0.00 |
Cardinal Health IncSOLE | COM | 30.30K | SH | $504.9K 1.87% | 504.85K | 0.00 | 0.00 |
UFP Technologies IncSOLE | COM | 22.99K | SH | $487.1K 1.81% | 487.08K | 0.00 | 0.00 |
Merus N.V.SOLE | COM | 48K | SH | $479.8K 1.78% | 479.77K | 0.00 | 0.00 |
Soleno Therapeutics IncSOLE | COM | 60.16K | SH | $431.7K 1.60% | 431.72K | 0.00 | 0.00 |
REVOLUTION Medicines IncSOLE | COM | 85.36K | SH | $423.2K 1.57% | 423.18K | 0.00 | 0.00 |
Amgen IncSOLE | COM | 13.81K | SH | $413.6K 1.53% | 413.62K | 0.00 | 0.00 |
Page 1 of 2